Shandong Teamgene Technology Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Teamgene Technology has a total shareholder equity of CN¥1.3B and total debt of CN¥171.5M, which brings its debt-to-equity ratio to 13.5%. Its total assets and total liabilities are CN¥1.8B and CN¥500.6M respectively. Shandong Teamgene Technology's EBIT is CN¥63.6M making its interest coverage ratio 54.6. It has cash and short-term investments of CN¥166.1M.
Key information
13.5%
Debt to equity ratio
CN¥171.50m
Debt
Interest coverage ratio | 54.6x |
Cash | CN¥166.12m |
Equity | CN¥1.27b |
Total liabilities | CN¥500.65m |
Total assets | CN¥1.77b |
Recent financial health updates
No updates
Recent updates
Shandong Teamgene Technology's (SHSE:603151) Problems Go Beyond Weak Profit
Nov 05The Returns On Capital At Shandong Teamgene Technology (SHSE:603151) Don't Inspire Confidence
Oct 16We Think That There Are More Issues For Shandong Teamgene Technology (SHSE:603151) Than Just Sluggish Earnings
May 03Shandong Teamgene Technology (SHSE:603151) May Have Issues Allocating Its Capital
Mar 05Financial Position Analysis
Short Term Liabilities: 603151's short term assets (CN¥940.8M) exceed its short term liabilities (CN¥463.2M).
Long Term Liabilities: 603151's short term assets (CN¥940.8M) exceed its long term liabilities (CN¥37.5M).
Debt to Equity History and Analysis
Debt Level: 603151's net debt to equity ratio (0.4%) is considered satisfactory.
Reducing Debt: 603151's debt to equity ratio has increased from 8.8% to 13.5% over the past 5 years.
Debt Coverage: 603151's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603151's interest payments on its debt are well covered by EBIT (54.6x coverage).